"The Mechanic" Cellular Energy Optimization Protocol

Your cells make energy the same way they did when you were twenty. The machinery is the same, the fuel sources are the same, and the basic chemistry has not changed. What changes is how well that machinery holds together, and that breakdown follows a predictable sequence that, once you understand it, makes every piece of this protocol obvious.

Start with the big picture. Inside every cell are mitochondria, and inside those mitochondria is a process called the electron transport chain, which is essentially a series of protein complexes arranged along the inner membrane that strip electrons from food and use them to pump protons across that membrane, building up a kind of electrical pressure that gets converted into ATP, which is the actual molecule your cells spend for energy. Everything downstream of that chain, every contraction, every nerve signal, every repair process, runs on that ATP production. The chain itself is not a machine that wears out randomly. It degrades through three specific failure points, and the protocol maps directly onto those three failure points.

The first failure point is structural. The inner mitochondrial membrane is folded into tight ridges called cristae, and the complexes of the electron transport chain are anchored along those folds. Keeping those folds intact requires a specialized phospholipid called cardiolipin, which acts like a molecular scaffold holding the whole architecture together. As cardiolipin gets damaged by oxidative stress over time, the folds flatten out, the complexes drift apart, and electrons start leaking out of the chain instead of completing their path. A leaking electron transport chain is less efficient at making ATP and generates more reactive oxygen species as a byproduct, which then damages more cardiolipin, which causes more leaking. That spiral is the structural failure.

The second failure point is metabolic. Your mitochondria cannot repair themselves, run their stress responses, or maintain gene expression without a molecule called NAD+, which is a coenzyme that shuttles electrons but also serves as the raw material for something called sirtuins and PARPs, which are the proteins responsible for cellular maintenance and DNA repair. NAD+ levels decline with age, but the mechanism is not passive. There is a protein called CD38, which is an enzyme that breaks down NAD+, and it becomes significantly more active as you get older, increasing roughly two to three fold with age. What drives that increase in CD38 is something called senescent cells, which are cells that have stopped dividing and should have died but instead stay in the tissue and release inflammatory signals. Those signals recruit immune cells that upregulate CD38, and the CD38 then degrades the NAD+ that the rest of your healthy cells need to function. So the senescence burden in your tissue is not just an inflammation problem. It is also directly draining the energy currency of the cells around it.

The third failure point is efficiency. Even when the membrane structure is intact and NAD+ is available, the mitochondria can become metabolically sluggish. The enzyme network that senses nutrient and energy status and coordinates how aggressively mitochondria produce ATP, that network becomes less responsive over time. The central node there is something called AMPK, which is essentially the cellular energy sensor that tells mitochondria to produce more ATP when energy demand is high. When AMPK signaling weakens, you can have structurally intact mitochondria with adequate cofactors and still not be getting full output from them.

Three failure points. Structural damage, NAD+ drain from senescence and CD38, and reduced AMPK-driven efficiency. The protocol sequences interventions in the order those problems need to be solved, because solving efficiency when the structure is damaged is like pressing harder on a gas pedal when the engine is full of cracks.

The foundation layer is straightforward and it is not where the interesting science lives, but it matters because everything downstream depends on adequate cofactors. CoQ10 is worth pausing on. It is sometimes framed as a general antioxidant supplement, but its actual role is mechanical. CoQ10, or coenzyme Q, is the mobile electron carrier between Complex I and Complex II on one side and Complex III on the other. Without it, electrons cannot complete the chain. CoQ10 levels decline with age and fall sharply with statin use, which explains why statins carry a muscle fatigue profile. Five grams of creatine per day feeds the phosphocreatine system that buffers ATP in high-demand tissue, particularly muscle and brain.

The repair phase starts with SS-31, which works directly at the cardiolipin level. SS-31 is a small tetrapeptide that carries a positive charge, which causes it to concentrate inside mitochondria where the membrane potential is negative. Once inside, it binds cardiolipin directly, stabilizing the inner membrane structure, restoring cristae architecture, and reducing electron leakage. The reduction in leakage matters both for efficiency and for oxidative stress, because a tighter chain produces less reactive oxygen species, which means less downstream cardiolipin damage. The dose in the protocol, one to two milligrams per day, is conservative. The four to eight week window is the period over which membrane remodeling occurs.

Then comes the senescence clearance. FOXO4-DRI works by interrupting a specific molecular handshake inside senescent cells. In healthy cells, a protein called p53 is free to trigger apoptosis, which is the cell death program, when something goes wrong. In senescent cells, a protein called FOXO4 grabs p53 and holds it in the nucleus, blocking that death signal and keeping the senescent cell alive. FOXO4-DRI is a modified peptide that competes for that binding, freeing p53 to trigger apoptosis specifically in the senescent cells. The selectivity here is meaningful. Research showed roughly eleven-fold preference for senescent cells over healthy cells, which is what makes the compound usable. The few days of feeling off that Josh mentions is the immune system clearing the apoptotic debris, which is an expected consequence of actually doing what the peptide is designed to do.

Once senescent burden drops, the mechanism driving CD38 upregulation weakens, and NAD+ levels have the opportunity to recover. That is the point at which niacin supplementation actually has a substrate to work with. The reason niacin rather than NMN or NR is worth explaining. Research published in 2020 and confirmed in 2025 showed that most oral NMN and NR get converted by gut bacteria into nicotinic acid, which is plain niacin, before absorption. The gut cannot distinguish the expensive precursor from the cheap one because by the time either reaches the blood, they have already been converted. Niacin does the same thing for pennies.

Exercise also matters here in a way that is mechanistically specific. A protein called NAMPT is the rate-limiting enzyme in the primary NAD+ synthesis pathway, and skeletal muscle NAMPT increases by roughly 127 percent in previously sedentary people after an exercise training program. That is a larger NAD+ boost than you will get from any supplement if you are sedentary, which is precisely why the protocol only makes sense sitting on top of actual training.

The optimization phase introduces MOTS-c, which is a peptide that is actually encoded inside mitochondrial DNA itself, making it one of the few known mitochondrially-derived signaling molecules. MOTS-c activates AMPK by inhibiting a branch of the folate cycle inside the mitochondria, which raises the AMP to ATP ratio locally and triggers AMPK to shift the cell into high-efficiency energy production mode. In animal models, MOTS-c prevented diet-induced insulin resistance and obesity, and the mechanism runs through that AMPK activation. The timing here is deliberate. Pushing AMPK hard on a damaged membrane does not help. But pushing it on a membrane that has been structurally restored for four to eight weeks gives the efficiency signal something to work with.

L-carnitine is the only molecule that can carry long-chain fatty acids across the inner mitochondrial membrane so they can be oxidized. Without adequate carnitine, fatty acid fuel cannot enter the mitochondria at all. Whether injectable carnitine provides a meaningful advantage over oral carnitine in non-deficient people is still a genuinely open question, but the transport mechanism itself is well established.

Most people think of cellular energy as a supplement problem. Take the right precursor, fill the tank, feel better. But the actual problem is structural and systemic, and it unfolds in a sequence. What this protocol represents is not a stack of molecules. It is a repair-then-optimize logic applied to a system that fails in a specific order. Fixing the membrane before clearing the senescent cells, clearing the senescent cells before trying to push NAD+ levels up, restoring structure before activating the efficiency signal. The sequence is the intervention.

---

References

1. Birk AV, Liu S, Soong Y, et al. The Mitochondrial-Targeted Compound SS-31 Re-Energizes Ischemic Mitochondria by Interacting with Cardiolipin. Journal of the American Society of Nephrology. 2013;248:1250-1261. Finding: SS-31 selectively binds cardiolipin on the inner mitochondrial membrane, stabilizing cristae structure. Source
2. Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. British Journal of Pharmacology. 2014;1718:2029-2050. Finding: SS-31 binds cardiolipin, stabilizes mitochondrial membrane structure, and reduces electron leakage and ROS production. Source
3. Baar MP, Brandt RMC, Putavet DA, et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. 2017;1691:132-147. Finding: FOXO4-DRI disrupts FOXO4-p53 interaction in senescent cells, freeing p53 to trigger apoptosis. 11.73-fold selectivity for senescent vs healthy cells. Source
4. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism. 2016;236:1127-1139. Finding: CD38 activity increases 2-3 fold with age. CD38 knockout mice maintained NAD+ levels at all ages. Source
5. Covarrubias AJ, Kale A, Perrone R, et al. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages. Nature Metabolism. 2020;211:1265-1283. Finding: Senescent cell SASP cytokines induce macrophages to upregulate CD38, establishing the causal chain from senescence to NAD+ decline. Source
6. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine. 2003;1356:590-592. Finding: Epithalon induced hTERT expression, telomerase activity, and telomere elongation in human fibroblasts. Source
7. Goncharova ND, Vengerin AA, Khavinson VKh, Lapin BA. Pineal peptides restore the age-related disturbances in hormonal functions of the pineal gland and the pancreas. Experimental Gerontology. 2005;401-2:51-57. Finding: Epithalamin at 5mg/day and synthetic Epithalon at 10mcg/day achieved equivalent melatonin restoration in aged monkeys, demonstrating 500-fold potency difference. Source
8. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;213:443-454. Finding: MOTS-c activates AMPK via inhibition of the folate cycle. Prevented insulin resistance and diet-induced obesity. Source
9. Shats I, Williams JG, Liu J, et al. Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway. Cell Metabolism. 2020;313:564-579. Finding: Gut bacteria deamidate nicotinamide to nicotinic acid niacin, confirming NMN/NR undergo gut conversion before absorption. Source
10. Kim LJ, et al. Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation. Science Advances. 2025. Finding: Most oral NMN and NR is converted to niacin-pathway metabolites in the gut before absorption. Source
11. Costford SR, Bajpeyi S, Pasarica M, et al. Skeletal muscle NAMPT is induced by exercise in humans. American Journal of Physiology - Endocrinology and Metabolism. 2010;2981:E117-E126. Finding: NAMPT protein increased 127% in sedentary subjects after exercise training. Source
12. Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochimica et Biophysica Acta. 2016;186310:2422-2435. Finding: L-carnitine is the sole molecule carrying long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation. Source
13. Banerjee R, Purhonen J, Bhardwaj R, Bhargava A, Kallijarvi J. The mitochondrial coenzyme Q junction and complex III. The FEBS Journal. 2022;28922:6936-6958. Finding: CoQ serves as the mobile electron carrier between Complex I/II and Complex III. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness